Drug
Anti Cxcr4
Anti Cxcr4: highest development phase Phase 1, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| Anti-CXCR4 (BMS-936564) NCT01359657 | Phase 1 | Multiple Myeloma |
Latest
No recent events.
Follow Anti Cxcr4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.